查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1912910

自動化磁珠純化系統市場：全球預測（2026-2032 年），依產能、應用和最終用戶分類

Fully Automatic Magnetic Bead Purification System Market by Throughput, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，自動化磁珠純化系統市場價值將達到 1.8572 億美元，到 2026 年將成長至 2.0318 億美元，到 2032 年將達到 3.2091 億美元，複合年成長率為 8.12%。

主要市場統計數據
基準年 2025 1.8572億美元
預計年份：2026年 2.0318億美元
預測年份：2032年 3.2091億美元
複合年成長率 (%) 8.12%

磁珠純化自動化如何透過在科研和臨床環境中提供一致性、可追溯性和靈活整合，從而改變實驗室工作流程

全自動輪胎邊緣純化系統將磁珠化學、機器人技術和流體控制相結合，實現了核酸和蛋白質純化的自動化，正迅速成為現代分子工作流程的核心組成部分。這些平台透過可程式設計程式取代重複的手動操作，提高了實驗的一致性，減少了人工操作時間，並提升了科學研究和臨床應用的通量。因此，實驗室可以將技術人員重新部署到分析和結果解讀工作中，同時減少手動移液操作帶來的變異性。

技術、操作和監管因素正在匯聚，重新定義自動化磁珠純化系統作為實現標準化和審核的實驗室工作流程的策略基礎的作用。

隨著技術、操作和監管因素的融合，全自動磁珠純化技術領域正經歷變革性的轉變，重新定義了樣品製備的預期。在技​​術層面，磁珠化學的成熟，以及液體處理精度和磁模組設計的改進，拓展了可可靠處理的基質和分析物範圍。因此，儀器不再是小眾的自動化工具，而是高效能定序中心、臨床診斷實驗室和工業生物加工流程的基礎組成部分。

2025年關稅調整如何推動自動化平台供應鏈韌性策略，並企業發展製造商的採購週期

2025年美國關稅政策的調整為自動化輪胎邊緣純化系統供應鏈中的相關人員帶來了新的成本和營運複雜性。進口設備零件和某些試劑關稅的提高迫使採購團隊重新評估供應商關係、零件籌資策略以及總到岸成本。為此，自動化平台製造商正在加快雙源採購的步伐，並選擇性地轉移關鍵生產流程，以降低關稅相關成本波動帶來的風險。

在實驗室自動化領域，容量等級、最終使用者需求和特定應用需求如何共同決定產品差異化、採購優先順序和供應商定位？

這種細分方法為理解不同實驗室環境和工作流程中的需求趨勢和產品適用性提供了切實可行的觀點。基於通量視角，設備選擇的優先順序差異顯著。高通量環境強調週期時間、試劑節省以及與機器人樣品處理的無縫整合。中等通量環境重視通訊協定的柔軟性和平台重新配置的便利性，而低通量環境則強調面積、操作簡便以及耗材使用成本低。這些差異導致供應商在產品開發重點和服務模式上有所不同，以因應不同的應用情境。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢，透過不同的監管環境、支持期望和製造重點，正在塑造供應商的策略。

區域趨勢正在以不同的方式影響美洲、歐洲、中東和非洲以及亞太地區的市場採用模式，並塑造供應商的策略。在美洲，大型實驗室、臨床檢測中心和合約檢測機構的需求驅動著市場，這些機構優先考慮整合工作流程和快速檢測結果交付。此外，對配套服務和在地化支援網路的需求也很強勁，這促使供應商投資建造區域服務中心和培訓計畫。同時，監管預期和報銷環境也在影響哪些診斷應用程式能夠最快被採用。

為什麼技術模組化、整合服務模式和透明的營運承諾決定了供應商的競爭力以及與客戶的長期夥伴關係？

競爭優勢取決於技術差異化、卓越服務以及在客戶環境中展現營運價值的能力。領先的供應商正在投資模組化平台架構，以支援多種化學方法和通訊協定庫，使客戶能夠將工作流程整合到單一自動化平台上。這種架構的柔軟性降低了培訓負擔，並加速了其在從診斷測試到高效能篩檢等各種應用領域的普及。

供應商應專注於模組化產品設計、供應鏈彈性以及以結果為導向的服務，以確保產品在研究和臨床試驗領域的應用。

為了滿足研發和臨床環境中對自動化純化日益成長的依賴，產業領導者應優先考慮能夠協調產品開發、供應鏈穩定性和以客戶為中心的服務模式的策略。首先，應投資於模組化平台設計，該設計支援多種磁珠化學性質、可變平台配置和軟體驅動的通訊協定庫，從而能夠在單一儀器上檢驗多種應用場景。這種方法能夠加速不同終端使用者對自動化純化技術的接受度，並降低客戶生命週期內的培訓和檢驗成本。

我們採用嚴謹的混合方法研究方法，結合一手訪談、技術文獻綜述和供應鏈分析，以確保為實驗室自動化利害關係人提供檢驗且經過驗證的見解。

支撐這些發現的研究結合了對核酸和蛋白質純化自動化相關最新技術文獻和監管指南的系統性回顧，以及對實驗室主任、採購人員和自動化工程師的訪談。主要資料收集著重於從學術機構到商業臨床檢查室等各類終端使用者的工作流程偏好、驗證挑戰和服務期望。受訪者的選擇旨在涵蓋地理多樣性和不同的能力水平，從而確保研究結果能夠反映集中式和分散式檢查環境中的實際操作情況。

本文探討了自動化、供應鏈彈性以及協同驗證將如何決定未來檢查室工作流程中的應用管道和供應商差異化。

總而言之，全自動磁珠純化系統正從專用自動化設備轉型為支援高品質、可重複分子工作流程的基礎檢查室基礎設施。磁珠化學、液體處理精度和軟體整合的技術進步正在拓展其應用範圍，而營運和監管壓力則推動了對檢驗和審核系統的需求。同時，關稅變動等外部因素也凸顯了供應鏈韌性和透明成本結構的重要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依處理能力分類的自動化磁珠純化系統市場

  • 高處理能力
  • 低處理能力
  • 中等處理能力

9. 按應用分類的自動化磁珠純化系統市場

  • 診斷測試
    • 癌症標記檢測
    • 遺傳疾病篩檢
    • 傳染病檢查
  • 藥物發現
    • 生物標記發現
    • 高效能篩檢
    • 鉛識別
  • 基因組學
    • RNA定序
    • 目標序列
    • 全基因組定序
  • 蛋白質體學
    • 質譜分析
    • 蛋白質晶片
    • 蛋白質印跡法

第10章 依最終用戶分類的自動化磁珠純化系統市場

  • 學術研究機構
  • 臨床檢查室
  • CRO（受託研究機構）
  • 製藥和生物技術公司

第11章 區域性自動化磁珠純化系統市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章 自動化磁珠純化系統市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 各國自動化磁珠純化系統市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章美國自動化磁珠純化系統市場

17. 中國自動化磁珠純化系統市場

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Hamilton Company
  • MGI Tech Co., Ltd.
  • Omega Bio-tek, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Roche Diagnostics International AG.
  • Tecan Group AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-AE420CB13B17

The Fully Automatic Magnetic Bead Purification System Market was valued at USD 185.72 million in 2025 and is projected to grow to USD 203.18 million in 2026, with a CAGR of 8.12%, reaching USD 320.91 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 185.72 million
Estimated Year [2026] USD 203.18 million
Forecast Year [2032] USD 320.91 million
CAGR (%) 8.12%

How automation in magnetic bead purification is reshaping laboratory workflows by delivering consistency, traceability, and flexible integration across research and clinical environments

Fully automatic magnetic bead purification systems have rapidly become central to modern molecular workflows by combining magnetic bead chemistry with robotics and fluidics to automate nucleic acid and protein cleanup. These platforms replace repetitive manual steps with programmable routines that improve consistency, reduce hands-on time, and enable higher throughput in both research and clinical settings. Consequently, laboratories can reallocate technical staff to analytical and interpretive tasks while reducing variability tied to manual pipetting.

Adoption is driven by an expanding range of applications that demand reliable sample preparation, from next-generation sequencing library preparation to high-sensitivity diagnostic assays. Manufacturers have iteratively refined hardware and consumable interfaces to support diverse bead chemistries and sample types, providing modularity for different workflows. At the same time, integration with laboratory information management systems and downstream instruments has strengthened, enabling traceability and facilitating compliance with regulatory and accreditation requirements. These advances set the stage for broader institutional adoption and for workflows that require reproducible, auditable sample preparation across distributed testing sites.

Converging technological, operational, and regulatory forces are redefining the role of automated magnetic bead purification systems as strategic enablers of standardized, auditable laboratory workflows

The landscape of fully automatic magnetic bead purification is undergoing transformative shifts as technological, operational, and regulatory forces converge to redefine expectations for sample preparation. Technologically, the maturation of bead chemistries alongside improvements in liquid handling precision and magnetic module design has expanded the range of matrices and analytes that can be reliably processed. As a result, instruments are no longer niche automation tools but foundational elements of high-throughput sequencing centers, clinical diagnostic labs, and industrial bioprocess pipelines.

Operationally, there is an increasing emphasis on workflow standardization and reproducibility. Laboratories are prioritizing systems that offer validated protocols for common applications such as RNA sequencing, targeted sequencing, and whole genome sequencing, as well as proteomics workflows that interface with mass spectrometry and protein array platforms. This shift is reinforced by the growing need to harmonize procedures across multi-site networks and contract research organizations. Concurrently, manufacturers are enhancing software ecosystems to offer protocol customization, user-access controls, and audit logs to support quality systems.

Regulatory and market pressures are also reshaping product roadmaps. Clinical diagnostics require instruments and consumables that meet stringent validation standards and support rapid assay turnaround without compromising sensitivity. Consequently, companies are investing in designs that minimize cross-contamination risks, simplify decontamination, and enable traceable sample tracking. In parallel, service models have shifted toward outcome-based offerings, with an increased focus on preventive maintenance, on-site validation assistance, and consumable management to guarantee uninterrupted operations. These combined shifts are driving a repositioning of automation providers from hardware vendors to strategic partners focused on enabling end-to-end laboratory value.

How 2025 tariff adjustments have catalyzed supply chain resilience strategies and reshaped sourcing, procurement cycles, and manufacturer footprints for automation platforms

United States tariff policy developments in 2025 have introduced new dimensions of cost and operational complexity for stakeholders in the supply chain of fully automatic magnetic bead purification systems. Increased duties on imported instrument components and certain reagents have prompted procurement teams to re-evaluate supplier relationships, component sourcing strategies, and total landed cost considerations. In response, manufacturers of automation platforms have accelerated dual-sourcing efforts and are selectively relocating critical manufacturing steps to mitigate exposure to tariff-related cost volatility.

The cumulative impact of these tariff changes has also been felt downstream by laboratories that rely on imported consumables and maintenance parts. Procurement cycles are lengthening as lab managers perform more rigorous supplier due diligence and negotiate longer-term supply contracts to secure price stability and inventory buffering. In addition, some organizations are experimenting with inventory rationalization strategies and consignment models to manage cash flow and reduce exposure to episodic price increases. Regulatory compliance and validation obligations further complicate rapid supplier substitutions, encouraging a cautious, staged approach to any change in consumables or service providers.

Despite these pressures, the sector has seen a parallel rise in collaborative sourcing and regional manufacturing partnerships. Technology providers are increasingly offering service bundles that include guaranteed parts availability and transparent cost models to preserve predictable operational budgets. Ultimately, tariff-driven disruption has catalyzed a strategic re-evaluation of supply chain resilience, prompting stakeholders to prioritize supplier diversification, transparent cost structures, and manufacturing footprints aligned with customer geographies and regulatory requirements.

How throughput tiers, end-user requirements, and application-specific demands converge to define product differentiation, procurement priorities, and vendor positioning in laboratory automation

Segmentation provides practical lenses to understand demand dynamics and product fit across different laboratory environments and workflows. Based on throughput considerations, instrument selection priorities vary significantly: high throughput environments prioritize cycle time, reagent conservation, and seamless integration with robotic sample handling, while medium throughput settings value flexibility across protocols and ease of deck reconfiguration, and low throughput sites emphasize footprint, ease of use, and cost-effective consumable usage. These differences drive distinct product development emphases and service models from vendors seeking to address each use case.

Based on end user distinctions, adoption drivers and purchasing pathways diverge. Academic and research institutes typically prioritize protocol versatility and compatibility with cutting-edge applications such as single-cell workflows and custom library preparations. Clinical diagnostics laboratories focus on validated, regulatory-compliant workflows with stringent contamination control and traceability. Contract research organizations value scalability, reproducibility across batches, and vendor support for high-turnaround projects. Pharma and biotechnology companies emphasize robust validation, integration with upstream and downstream process equipment, and long-term service agreements that align with drug development timelines.

Based on application segmentation, platform capabilities must align with specific analytical goals. Diagnostic testing workflows require high sensitivity and contamination mitigation for cancer marker detection, genetic disorder screening, and infectious disease testing. Drug discovery applications demand adaptability for biomarker discovery, high-throughput screening, and lead identification, with an emphasis on throughput and cross-run consistency. Genomics applications such as RNA sequencing, targeted sequencing, and whole genome sequencing necessitate precision in yield and fragment-size recovery, coupled with low sample-to-sample variability. Proteomics workflows, including mass spectrometry, protein arrays, and western blotting, require optimized bead chemistries and sample cleanup protocols that preserve protein integrity and compatibility with downstream detection methods. Recognizing these segmentation-driven priorities enables more targeted product roadmaps and support services.

Regional dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific are shaping vendor strategies through distinct regulatory landscapes, support expectations, and manufacturing priorities

Regional dynamics are influencing adoption patterns and shaping vendor strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific in distinct ways. In the Americas, demand is driven by large research institutions, clinical reference laboratories, and contract operations that prioritize integrated workflows and rapid assay turnaround. There is also a strong appetite for bundled services and localized support networks, which encourages vendors to invest in regional service centers and training programs. At the same time, regulatory expectations and reimbursement environments influence which diagnostic applications see the fastest adoption.

Europe, the Middle East & Africa present a mosaic of regulatory environments and laboratory capabilities, which increases the importance of flexible validation support and multi-language software interfaces. Laboratories in these regions often emphasize compliance, interoperability with national health systems, and demonstrable contamination control, which shapes procurement criteria. Vendors that can navigate diverse regulatory pathways and provide robust after-sales support gain competitive advantage. Moreover, collaborative research networks in this region are fostering cross-border standardization efforts that benefit from automation-driven reproducibility.

Asia-Pacific exhibits rapid capacity expansion in genomics and clinical diagnostics, supported by sizable investments in sequencing infrastructure and decentralized testing networks. Local manufacturing capabilities and an emphasis on cost-competitive solutions shape vendor strategies, leading many suppliers to pursue regional partnerships and localized production to shorten lead times. Additionally, emerging diagnostic markets in the region are driving demand for compact, user-friendly systems that can operate in both centralized and decentralized laboratory footprints. These regional nuances collectively influence how vendors prioritize product features, service models, and manufacturing investments.

Why technological modularity, integrated service models, and transparent operational commitments determine vendor competitiveness and long-term customer partnerships

Competitive dynamics hinge on a combination of technological differentiation, service excellence, and the ability to demonstrate operational value in customer environments. Leading suppliers are investing in modular platform architectures that support multiple chemistries and protocol libraries, enabling customers to consolidate workflows onto a single automation backbone. This architectural flexibility reduces training overhead and accelerates adoption across diverse applications, from diagnostic testing to high-throughput discovery.

Service and lifecycle support are also central competitive levers. Vendors that provide proactive maintenance, rapid parts availability, and validation assistance strengthen long-term customer relationships. In parallel, partnerships with consumable manufacturers, reagent suppliers, and software integrators enable suppliers to offer cohesive solutions rather than standalone instruments. Strategic collaborations with academic centers and contract research organizations for co-development and protocol optimization further validate technology platforms and create reference use cases that aid commercial adoption.

Finally, transparency in total cost of ownership components-such as consumable consumption rates, scheduled maintenance windows, and software licensing models-has become a decision-making criterion for procurement officers. Manufacturers that couple technical performance with predictable operational models and clear support commitments are better positioned to secure long-term contracts and enterprise deployments.

Practical strategic priorities for vendors to align modular product design, supply resilience, and outcome-based services to secure adoption across research and clinical laboratory segments

Industry leaders should prioritize strategies that align product development, supply resilience, and customer-centric service models to capture the growing reliance on automated purification in both research and clinical settings. First, invest in modular platform design that supports multiple bead chemistries, variable deck configurations, and software-driven protocol libraries so that a single instrument can be validated across multiple use cases. This approach accelerates adoption among diverse end users and reduces total lifecycle training and validation costs for customers.

Second, strengthen supply chain resilience through diversified sourcing, regional manufacturing partnerships, and transparent spare-parts inventories. Such measures mitigate exposure to tariff-driven price volatility and shorten lead times for critical consumables. Third, expand service offerings to include outcome-oriented contracts that bundle preventive maintenance, consumable replenishment, and validation support; these commitments enhance customer confidence and reduce operational risk. Fourth, deepen collaborations with end users-academic centers, clinical labs, CROs, and pharma-to co-develop validated protocols for priority applications such as RNA sequencing, targeted sequencing, biomarker discovery, and diagnostic assays. These collaborations generate reference data, streamline regulatory submissions, and accelerate time-to-value for customers.

Finally, invest in training and digital support ecosystems that facilitate remote troubleshooting, protocol version control, and integration with laboratory information systems. By focusing on these strategic priorities, suppliers can convert technological capabilities into sustained operational advantage and become indispensable partners for laboratories navigating complex workflows and regulatory obligations.

A rigorous mixed-methods research approach combining primary interviews, technical literature review, and supply chain analysis to ensure actionable and validated insights for laboratory automation stakeholders

The research underpinning these insights combined primary interviews with laboratory directors, procurement leads, and automation engineers, alongside a structured review of recent technical literature and regulatory guidance relevant to nucleic acid and protein purification automation. Primary data collection focused on workflow preferences, validation pain points, and service expectations across a range of end users, from academic centers to commercial clinical laboratories. Interviews were selected to capture geographic diversity and different throughput profiles to ensure the findings reflect operational realities in centralized and decentralized testing environments.

Secondary research emphasized protocol adoption trends, advances in bead chemistries, and the evolution of liquid handling and magnetic module designs. Supply chain analysis incorporated publicly available trade and policy updates to assess potential impacts on component sourcing and regional manufacturing decisions. Where applicable, validation and regulatory guidance documents were reviewed to align product and service recommendations with current compliance expectations. Throughout the research, triangulation of multiple data sources was applied to ensure robustness, and findings were reviewed by subject-matter experts to validate technical accuracy and practical relevance.

Concluding synthesis on how automation, supply resilience, and collaborative validation define future adoption pathways and vendor differentiation in laboratory workflows

In summary, fully automatic magnetic bead purification systems are transitioning from specialized automation to foundational laboratory infrastructure that supports high-quality, reproducible molecular workflows. Technological refinements in bead chemistry, liquid handling fidelity, and software integration are expanding the range of compatible applications, while operational and regulatory pressures are driving demand for validated, auditable systems. At the same time, external forces such as tariff changes have highlighted the importance of supply chain resilience and transparent cost structures.

Segmentation by throughput, end user, and application clarifies why different laboratories prioritize distinct instrument attributes and service models. Regional dynamics further influence procurement and deployment strategies, with the Americas emphasizing integrated support, Europe, Middle East & Africa prioritizing regulatory and interoperability considerations, and Asia-Pacific balancing rapid capacity expansion with cost competitiveness. Competitive advantage accrues to vendors that pair modular technical platforms with comprehensive service and supply solutions, and that engage collaboratively with customers to co-develop validated workflows. Stakeholders who act on these insights will be better positioned to realize the efficiency, reliability, and scalability benefits that automated purification systems can deliver.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Fully Automatic Magnetic Bead Purification System Market, by Throughput

  • 8.1. High Throughput
  • 8.2. Low Throughput
  • 8.3. Medium Throughput

9. Fully Automatic Magnetic Bead Purification System Market, by Application

  • 9.1. Diagnostic Testing
    • 9.1.1. Cancer Marker Detection
    • 9.1.2. Genetic Disorder Screening
    • 9.1.3. Infectious Disease Testing
  • 9.2. Drug Discovery
    • 9.2.1. Biomarker Discovery
    • 9.2.2. High-Throughput Screening
    • 9.2.3. Lead Identification
  • 9.3. Genomics
    • 9.3.1. RNA Sequencing
    • 9.3.2. Targeted Sequencing
    • 9.3.3. Whole Genome Sequencing
  • 9.4. Proteomics
    • 9.4.1. Mass Spectrometry
    • 9.4.2. Protein Arrays
    • 9.4.3. Western Blotting

10. Fully Automatic Magnetic Bead Purification System Market, by End User

  • 10.1. Academic And Research Institutes
  • 10.2. Clinical Diagnostics Laboratories
  • 10.3. Contract Research Organizations
  • 10.4. Pharma And Biotechnology Companies

11. Fully Automatic Magnetic Bead Purification System Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Fully Automatic Magnetic Bead Purification System Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Fully Automatic Magnetic Bead Purification System Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Fully Automatic Magnetic Bead Purification System Market

15. China Fully Automatic Magnetic Bead Purification System Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Agilent Technologies, Inc.
  • 16.6. Bio-Rad Laboratories, Inc.
  • 16.7. Danaher Corporation
  • 16.8. Hamilton Company
  • 16.9. MGI Tech Co., Ltd.
  • 16.10. Omega Bio-tek, Inc.
  • 16.11. PerkinElmer, Inc.
  • 16.12. Promega Corporation
  • 16.13. QIAGEN N.V.
  • 16.14. Roche Diagnostics International AG.
  • 16.15. Tecan Group AG
  • 16.16. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY HIGH THROUGHPUT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY HIGH THROUGHPUT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY HIGH THROUGHPUT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY LOW THROUGHPUT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY LOW THROUGHPUT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY LOW THROUGHPUT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY MEDIUM THROUGHPUT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY MEDIUM THROUGHPUT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY MEDIUM THROUGHPUT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY CANCER MARKER DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY CANCER MARKER DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY CANCER MARKER DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENETIC DISORDER SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENETIC DISORDER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENETIC DISORDER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY LEAD IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY LEAD IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY LEAD IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY RNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY RNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEIN ARRAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEIN ARRAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEIN ARRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY WESTERN BLOTTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY WESTERN BLOTTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PHARMA AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PHARMA AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PHARMA AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GCC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GCC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 154. GCC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. GCC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 156. GCC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 157. GCC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 158. GCC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 159. GCC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. G7 FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. G7 FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 178. G7 FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. G7 FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 180. G7 FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 181. G7 FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 182. G7 FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 183. G7 FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. NATO FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. NATO FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 186. NATO FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. NATO FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 188. NATO FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 189. NATO FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 190. NATO FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 191. NATO FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)